Literature DB >> 10523548

Rapid identification of Candida dubliniensis with commercial yeast identification systems.

D H Pincus1, D C Coleman, W R Pruitt, A A Padhye, I F Salkin, M Geimer, A Bassel, D J Sullivan, M Clarke, V Hearn.   

Abstract

Candida dubliniensis is a newly described species that is closely related phylogenetically to Candida albicans and that is commonly associated with oral candidiasis in human immunodeficiency virus-positive patients. Several recent studies have attempted to elucidate phenotypic and genotypic characteristics of use in separating the two species. However, results obtained with simple phenotypic tests were too variable and tests that provided more definitive data were too complex for routine use in the clinical laboratory setting. The objective of this study was to determine if reproducible identification of C. dubliniensis could be obtained with commercial identification kits. The substrate reactivity profiles of 80 C. dubliniensis isolates were obtained by using the API 20C AUX, ID 32 C, RapID Yeast Plus, VITEK YBC, and VITEK 2 ID-YST systems. The percentages of C. dubliniensis isolates capable of assimilating or hydrolyzing each substrate were compared with the percentages from the C. albicans profiles in each kit's database, and the results were expressed as percent C. dubliniensis and percent C. albicans. Any substrate that showed >50% difference in reactivity was considered useful in differentiating the species. In addition, assimilation of methyl-alpha-D-glucoside (MDG), D-trehalose (TRE), and D-xylose (XYL) by the same isolates was investigated by the traditional procedure of Wickerham and Burton (L. J. Wickerham and K. A. Burton, J. Bacteriol. 56:363-371, 1948). At 48 h (the time recommended by the manufacturer for its new database), we found that the assimilation of four carbohydrates in the API 20C AUX system could be used to distinguish the species, i.e., glycerol (GLY; 88 and 14%), XYL (0 and 88%), MDG (0 and 85%), and TRE (15 and 97%). Similarly, results with the ID 32 C system at 48 h showed that XYL (0 and 98%), MDG (0 and 98%), lactate (LAT; 0 and 96%), and TRE (30 and 96%) could be used to separate the two species. Phosphatase (PHS; 9 and 76%) and alpha-D-glucosidase (23 and 94%) proved to be the most useful for separation of the species in the RapID Yeast Plus system. While at 24 h the profiles obtained with the VITEK YBC system showed that MDG (10 and 95%), XYL (0 and 95%), and GLY (26 and 80%) could be used to separate the two species, at 48 h only XYL (6 and 95%) could be used to separate the two species. The most useful substrates in the VITEK 2 ID-YST system were TRE (1 and 89%), MDG (1 and 99%), LAT (4 and 98%), and PHS (83 and 1%). While the latter kit was not yet commercially available at the time of the study, it would appear to be the most valuable for the identification of C. dubliniensis. Although assimilation of MDG, TRE, and XYL proved to be the most useful for species differentiation by the majority of commercial systems, the results with these carbohydrates by the Wickerham and Burton procedure were essentially the same for both species, albeit following protracted incubation. Thus, it is the rapidity of the assimilation achieved with the commercial systems that allows the differentiation of C. dubliniensis from C. albicans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523548      PMCID: PMC85686     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States.

Authors:  I F Salkin; W R Pruitt; A A Padhye; D Sullivan; D Coleman; D H Pincus
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

2.  Prevalence of Candida dubliniensis isolates in a yeast stock collection.

Authors:  F C Odds; L Van Nuffel; G Dams
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

3.  Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis.

Authors:  S Joly; C Pujol; M Rysz; K Vargas; D R Soll
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

4.  Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences.

Authors:  Samantha M Donnelly; Derek J Sullivan; Diarmuid B Shanley; David C Coleman
Journal:  Microbiology       Date:  1999-08       Impact factor: 2.777

Review 5.  Candida dubliniensis: an emerging opportunistic pathogen.

Authors:  D Sullivan; D Coleman
Journal:  Curr Top Med Mycol       Date:  1997-12

6.  Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.

Authors:  P Boerlin; F Boerlin-Petzold; C Durussel; M Addo; J L Pagani; J P Chave; J Bille
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes.

Authors:  J Bikandi; R S Millán; M D Moragues; G Cebas; M Clarke; D C Coleman; D J Sullivan; G Quindós; J Pontón
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.

Authors:  J F Meis; M Ruhnke; B E De Pauw; F C Odds; W Siegert; P E Verweij
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

9.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

10.  Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.

Authors:  M J McCullough; K V Clemons; D A Stevens
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

View more
  44 in total

1.  One-year prevalence of Candida dublinienis in a Dutch university hospital.

Authors:  J F Meis; F M Lunel; P E Verweij; A Voss
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.

Authors:  M A Jabra-Rizk; W A Falkler; W G Merz; A A Baqui; J I Kelley; T F Meiller
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.

Authors:  Preeti Pancholi; Steven Park; David Perlin; Christine Kubin; Phyllis Della-Latta
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

4.  Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card.

Authors:  D Jane Hata; Leslie Hall; Annette W Fothergill; Davise H Larone; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

5.  Detection of Candida dubliniensis in Venezuela.

Authors:  Claudia Hartung de Capriles; Sofía Mata-Essayag; Celina Pérez; Maria Teresa Colella; Arantza Roselló; Carolina Olaizola; Sylvia Magaldi Teresa Abate
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

6.  Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system.

Authors:  Yingjun Yan; Ying He; Thomas Maier; Criziel Quinn; Gongyi Shi; Haijing Li; Charles W Stratton; Markus Kostrzewa; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

7.  Rapid identification and differentiation of Candida albicans and Candida dubliniensis by capillary-based amplification and fluorescent probe hybridization.

Authors:  Rangaraj Selvarangan; Ajit P Limaye; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

8.  Methods of Candida dubliniensis identification and its occurrence in human clinical material.

Authors:  Martina Mahelová; Filip Růžička
Journal:  Folia Microbiol (Praha)       Date:  2017-05-17       Impact factor: 2.099

9.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Genetic differences between avian and human isolates of Candida dubliniensis.

Authors:  Brenda A McManus; Derek J Sullivan; Gary P Moran; Christophe d'Enfert; Marie Elisabeth Bougnoux; Miles A Nunn; David C Coleman
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.